Article
Intravitreal triamcinolone favorable in treating persistent DME
Fort Lauderdale, FL-In the short term, intravitreal triamcinolone acetonide (4 mg) reduces the risk of progressive loss of vision and commonly improves vision in patients with diabetic cystoid foveal edema that persists after laser treatment, said Mark C. Gillies, MD, PhD, at the annual meeting of the Association for Research in Vision and Ophthalmology.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
